Countries citing scholars working at Novartis (United States)
Since Specialization
Citations
This map shows the geographic impact of research produced by authors working at Novartis (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novartis (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novartis (United States) more than expected).
Fields of papers published by authors at Novartis (United States)
This network shows the impact of papers affiliated with Novartis (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Novartis (United States) at the time of their publication.
About Novartis (United States)
In recent decades, authors affiliated with Novartis (United States) have published 7.9k papers, which have received a total of 429.7k indexed citations . Scholars at this organization have produced 757 papers in Hematology, 664 papers in Genetics, 969 papers in Oncology, 628 papers in Immunology and 417 papers in Rheumatology on the topics of Chronic Myeloid Leukemia Treatments (349 papers), Chronic Lymphocytic Leukemia Research (280 papers), Computational Drug Discovery Methods (214 papers), Heart Failure Treatment and Management (213 papers), Hemoglobinopathies and Related Disorders (197 papers), CAR-T cell therapy research (185 papers), Statistical Methods in Clinical Trials (182 papers) and Advanced Breast Cancer Therapies (170 papers). Their work is cited by papers focused on Oncology (71.2k citations), Genetics (27.7k citations), Hematology (29.8k citations), Molecular Biology (129.4k citations) and Immunology (37.2k citations). Authors at Novartis (United States) collaborate with scholars in United States, Switzerland and United Kingdom and have published in prestigious journals including Blood, Annals of Oncology, Value in Health, Current Medical Research and Opinion and The Journal of Clinical Pharmacology. Some of Novartis (United States)'s most productive authors include David J. Glass, Peter Wisdom Atadja, William R. Sellers, Derek T. O’Hagan, Scott David Solomon, John J.V. McMurray, James Edward Foley, Taiping Chen, Michael R. Zile and Milton Packer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.
Explore institutions with similar magnitude of impact